Condensed Consolidated Statement of Changes in Stockholders' Equity - USD ($) $ in Thousands | Total | Common Stock | Treasury Stock | Additional Paid-In Capital | Accumulated Other Comprehensive Loss | Accumulated Deficit |
Balance at beginning of period at Dec. 31, 2017 | $ 83,139 | $ 5 | $ (8,443) | $ 288,277 | $ (232) | $ (196,468) |
Balance at beginning of period (in shares) at Dec. 31, 2017 | | 55,136,038 | 3,845,496 | | | |
Increase (Decrease) in Stockholders' Equity | | | | | | |
Exercise of stock options awards | 1,018 | | | 1,018 | | |
Exercise of stock options awards (in shares) | | 314,711 | | | | |
Stock-based compensation expense | 856 | | | 856 | | |
Common stock issued for settlement of restricted stock units net of shares withheld to satisfy income tax withholding obligations | (912) | | | (912) | | |
Common stock issued for settlement of restricted stock units net of shares withheld to satisfy income tax withholding obligations (in shares) | | 433,317 | | | | |
Common stock issuance in connection with employee stock purchase plan | 240 | | | 240 | | |
Common stock issuance in connection with employee stock purchase plan (in shares) | | 84,415 | | | | |
Net loss | (6,101) | | | | | (6,101) |
Foreign currency translation adjustment | (70) | | | | (70) | |
Balance at end of period at Mar. 31, 2018 | 78,170 | $ 5 | $ (8,443) | 289,479 | (302) | (202,569) |
Balance at end of period (in shares) at Mar. 31, 2018 | | 55,968,481 | 3,845,496 | | | |
Balance at beginning of period at Dec. 31, 2017 | 83,139 | $ 5 | $ (8,443) | 288,277 | (232) | (196,468) |
Balance at beginning of period (in shares) at Dec. 31, 2017 | | 55,136,038 | 3,845,496 | | | |
Increase (Decrease) in Stockholders' Equity | | | | | | |
Net loss | (10,801) | | | | | |
Foreign currency translation adjustment | (417) | | | | | |
Balance at end of period at Sep. 30, 2018 | 75,809 | $ 5 | $ (8,443) | 292,166 | (649) | (207,269) |
Balance at end of period (in shares) at Sep. 30, 2018 | | 56,813,104 | 3,845,496 | | | |
Balance at beginning of period at Mar. 31, 2018 | 78,170 | $ 5 | $ (8,443) | 289,479 | (302) | (202,569) |
Balance at beginning of period (in shares) at Mar. 31, 2018 | | 55,968,481 | 3,845,496 | | | |
Increase (Decrease) in Stockholders' Equity | | | | | | |
Exercise of stock options awards | 160 | $ 0 | | 160 | | |
Exercise of stock options awards (in shares) | | 84,535 | | | | |
Stock-based compensation expense | 980 | | | 980 | | |
Common stock issued for settlement of restricted stock units net of shares withheld to satisfy income tax withholding obligations | (103) | | | (103) | | |
Common stock issued for settlement of restricted stock units net of shares withheld to satisfy income tax withholding obligations (in shares) | | 206,248 | | | | |
Net loss | (3,119) | | | | | (3,119) |
Foreign currency translation adjustment | (202) | | | | (202) | |
Balance at end of period at Jun. 30, 2018 | 75,885 | $ 5 | $ (8,443) | 290,516 | (504) | (205,688) |
Balance at end of period (in shares) at Jun. 30, 2018 | | 56,259,264 | 3,845,496 | | | |
Increase (Decrease) in Stockholders' Equity | | | | | | |
Exercise of stock options awards | 598 | $ 0 | | 598 | | |
Exercise of stock options awards (in shares) | | 392,488 | | | | |
Stock-based compensation expense | 933 | | | 933 | | |
Common stock issued for settlement of restricted stock units net of shares withheld to satisfy income tax withholding obligations | (164) | | | (164) | | |
Common stock issued for settlement of restricted stock units net of shares withheld to satisfy income tax withholding obligations (in shares) | | 68,004 | | | | |
Common stock issuance in connection with employee stock purchase plan | 283 | | | 283 | | |
Common stock issuance in connection with employee stock purchase plan (in shares) | | 93,348 | | | | |
Net loss | (1,581) | | | | | (1,581) |
Foreign currency translation adjustment | (145) | | | | (145) | |
Balance at end of period at Sep. 30, 2018 | 75,809 | $ 5 | $ (8,443) | 292,166 | (649) | (207,269) |
Balance at end of period (in shares) at Sep. 30, 2018 | | 56,813,104 | 3,845,496 | | | |
Balance at beginning of period at Dec. 31, 2018 | 54,395 | $ 4 | $ (31,980) | 293,154 | (949) | (205,834) |
Balance at beginning of period (in shares) at Dec. 31, 2018 | | 56,956,935 | 12,564,240 | | | |
Increase (Decrease) in Stockholders' Equity | | | | | | |
Exercise of stock options awards | 3,181 | | | 3,181 | | |
Exercise of stock options awards (in shares) | | 825,349 | | | | |
Stock-based compensation expense | 1,083 | | | 1,083 | | |
Common stock issued for settlement of restricted stock units net of shares withheld to satisfy income tax withholding obligations | (536) | | | (536) | | |
Common stock issued for settlement of restricted stock units net of shares withheld to satisfy income tax withholding obligations (in shares) | | 280,808 | | | | |
Common stock issuance in connection with employee stock purchase plan | 270 | | | 270 | | |
Common stock issuance in connection with employee stock purchase plan (in shares) | | 87,671 | | | | |
Net loss | (4,333) | | | | | (4,333) |
Foreign currency translation adjustment | (232) | | | | (232) | |
Balance at end of period at Mar. 31, 2019 | 53,828 | $ 4 | $ (31,980) | 297,152 | (1,181) | (210,167) |
Balance at end of period (in shares) at Mar. 31, 2019 | | 58,150,763 | 12,564,240 | | | |
Balance at beginning of period at Dec. 31, 2018 | 54,395 | $ 4 | $ (31,980) | 293,154 | (949) | (205,834) |
Balance at beginning of period (in shares) at Dec. 31, 2018 | | 56,956,935 | 12,564,240 | | | |
Increase (Decrease) in Stockholders' Equity | | | | | | |
Net loss | (8,617) | | | | | |
Foreign currency translation adjustment | 120 | | | | | |
Balance at end of period at Sep. 30, 2019 | 56,136 | $ 4 | $ (31,980) | 303,393 | (829) | (214,452) |
Balance at end of period (in shares) at Sep. 30, 2019 | | 59,111,023 | 12,564,240 | | | |
Balance at beginning of period at Mar. 31, 2019 | 53,828 | $ 4 | $ (31,980) | 297,152 | (1,181) | (210,167) |
Balance at beginning of period (in shares) at Mar. 31, 2019 | | 58,150,763 | 12,564,240 | | | |
Increase (Decrease) in Stockholders' Equity | | | | | | |
Exercise of stock options awards | 611 | | | 611 | | |
Exercise of stock options awards (in shares) | | 149,478,000 | | | | |
Stock-based compensation expense | 2,020 | | | 2,020 | | |
Common stock issued for settlement of restricted stock units net of shares withheld to satisfy income tax withholding obligations | (197) | | | (197) | | |
Common stock issued for settlement of restricted stock units net of shares withheld to satisfy income tax withholding obligations (in shares) | | 74,768,000 | | | | |
Net loss | (1,484) | | | | | (1,484) |
Foreign currency translation adjustment | 212 | | | | 212 | |
Balance at end of period at Jun. 30, 2019 | 54,990 | $ 4 | $ (31,980) | 299,586 | (969) | (211,651) |
Balance at end of period (in shares) at Jun. 30, 2019 | | 58,375,009 | 12,564,240 | | | |
Increase (Decrease) in Stockholders' Equity | | | | | | |
Exercise of stock options awards | 2,077 | | | 2,077 | | |
Exercise of stock options awards (in shares) | | 508,570,000 | | | | |
Stock-based compensation expense | 1,868 | | | 1,868 | | |
Common stock issued for settlement of restricted stock units net of shares withheld to satisfy income tax withholding obligations | (377) | | | (377) | | |
Common stock issued for settlement of restricted stock units net of shares withheld to satisfy income tax withholding obligations (in shares) | | 176,940,000 | | | | |
Common stock issuance in connection with employee stock purchase plan | 239 | | | 239 | | |
Common stock issuance in connection with employee stock purchase plan (in shares) | | 50,504,000 | | | | |
Net loss | (2,801) | | | | | (2,801) |
Foreign currency translation adjustment | 140 | | | | 140 | |
Balance at end of period at Sep. 30, 2019 | $ 56,136 | $ 4 | $ (31,980) | $ 303,393 | $ (829) | $ (214,452) |
Balance at end of period (in shares) at Sep. 30, 2019 | | 59,111,023 | 12,564,240 | | | |